NASDAQ · PHARMACEUTICAL PREPARATIONS · LARGE CAP
Pharvaris N.v. PHVS
8 fiscal years on record · EUR · FY2025 reported · SEC filings only
€-175.7M
€-137.2M
Growth
—
Revenue, FY2025 · full 8-year series below
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
—
ROE
Not available in our data for this period.
The 8-year record
8 fiscal years
Every figure from documents filed with the SEC · EUR
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue €B | · | · | · | · | · | · | · | · |
| Operating income €B | −0.2 | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA €B | · | · | · | · | · | · | · | · |
| Income tax €B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 |
| Net income €B | −0.2 | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 | −0.0 | · |
| Free cash flow €B | −0.1 | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted € | −2.97 | −2.48 | −2.63 | −2.27 | −1.40 | · | · | · |
| Dividend / sh € | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · |
| ROE % | · | · | · | · | · | · | · | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 2 failures in 20 reconciliationsAUDITED
Reconciled in 6 of 19 fiscal years. 37 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente2 failures
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inoutside the United States — SEC code P7
Fiscal year endsDecember 31
Data on record since2018